Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$14.73 - $35.25 $147,300 - $352,500
-10,000 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$46.76 - $136.27 $467,600 - $1.36 Million
10,000 New
10,000 $810,000

Others Institutions Holding CVAC

About CureVac N.V.


  • Ticker CVAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,467,008
  • Market Cap $542M
  • Description
  • CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...
More about CVAC
Track This Portfolio

Track Varma Mutual Pension Insurance CO Portfolio

Follow Varma Mutual Pension Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Varma Mutual Pension Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Varma Mutual Pension Insurance CO with notifications on news.